

The Science and Supply of GLP-1s with Brooke Boyarsky Pratt
15 snips Jun 4, 2024
Brooke Boyarsky Pratt, CEO of knownwell, discusses obesity medicine, patient-centric care, and the future of metabolic health. Topics include GLP-1s for insulin regulation, improving patient access to medications, and the founder's transition from business to healthcare passion.
AI Snips
Chapters
Transcript
Episode notes
Founder's Personal Patient Journey
- Brooke Boyarsky Pratt founded Noenwell based on her personal experience as a patient struggling with obesity throughout her life.
- Her early health encounters framed her view on healthcare interactions around body size and motivated her to create a patient-centered obesity care model.
Obesity Medicine Specialty Insights
- Obesity medicine is a relatively new specialty officially recognized in 2012 with a board certification.
- It focuses on comprehensive treatment of obesity and related metabolic conditions beyond just addressing weight cosmetically.
Improving Obesity Care Infrastructure
- Primary care doctors often lack sufficient training and resources to treat obesity effectively.
- To improve care, clinics should integrate dieticians, health coaches, behavioral health, and streamlined medication management.